ArticleActa Cardiologica Sinica2026
Thoracic Mycotic Aortic Aneurysm with Aortoesophageal Fistula and Uniformly Fatal Outcomes, a Case Series and Focused Literature Review.
Article in Acta Cardiologica Sinica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Thoracic mycotic aortic aneurysm with aortoesophageal fistula (TMAA-AEF) is rare and highly lethal. However, limited data are available on imaging evolution and factors precluding transition to definitive surgery. Methods: This retrospective, single-center case series included all consecutive adults with TMAA-AEF over a 10-year period. AEF was classified using predefined criteria; computed tomography (CT) studies were reviewed by two blinded radiologists with concordance assessed by percentage agreement. A focused review of 19 published studies was performed. Results: Four patients (three women; median age, 77 years) with severe comorbidities presented with sepsis and upper gastrointestinal hemorrhage. CT demonstrated saccular aneurysms, periaortic inflammation, and loss of the aortoesophageal fat plane in all cases, and periaortic gas and contrast extravasation in three of the four cases. Serial imaging showed rapid progression to pseudoaneurysm and, after thoracic endovascular aortic repair (TEVAR), peri-graft abscess. Three patients underwent emergency TEVAR (median, 8 days); one received supportive care after cardiac arrest. All four died; none reached definitive open reconstruction. Conclusions: All of the patients in this series died. Failure to achieve staged open reconstruction, driven by advanced sepsis and hemodynamic instability, was the common terminal pathway regardless of TEVAR use. No efficacy conclusion about TEVAR can be drawn from these data. Pre-planned multidisciplinary pathways to definitive surgery are essential in TMAA-AEF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.